Table 3 Respiratory pathogens co-infections detected in COVID-19 patients.
No. of infection | ||||
|---|---|---|---|---|
|  | Double* (Coinfection) | 3* Coinfections | > 3 Coinfections | Total* |
| Â | n (%) | n (%) | n (%) | n (%) |
HCOV HKU1 | 1(3.7) | 4(16.7) | 18(26.1) | 23(19.2) |
K. pneumoniae | 13(48.1) | 3(12.5) | 9(13) | 25(20.8) |
IAV (H1N1) Swl | 0(0) | 2(8.3) | 10(14.5) | 12(10) |
HAdV | 2(7.4) | 4(16.7) | 14(20.3) | 20(16.7) |
P. Jirovecii | 1(3.7) | 2(8.3) | 21(30.4) | 24(20) |
HPIV4 | 0(0) | 2(8.3) | 18(26.1) | 20(16.7) |
EV | 0(0) | 2(8.3) | 20(29) | 22(18.3) |
Bordetella | 1(3.7) | 4(16.7) | 10(14.5) | 15(12.5) |
H. Influenza B | 0(0) | 0(0) | 0(0) | 0(0) |
HCOV NL63 | 0(0) | 1(4.2) | 12(17.4) | 13(10.8) |
S. aureus | 2(7.4) | 0(0) | 5(7.2) | 7(5.8) |
HRV | 0(0) | 0(0) | 14(20.3) | 14(11. 7) |
IBV | 0(0) | 1(4.2) | (0) | 1(0.8) |
M. Catarrhalis | 1(3.7) | 3(12.5) | 7(10.1) | 11(9.2) |
HPIV1 | 0(0) | 4(16.7) | 14(20.3) | 18(15) |
S. pneumoniae | 2(7.4) | 1(4.2) | 5(7.2) | 8(6.7) |
Salmonella | 0(0) | 0(0) | 12(17.4) | 12(10) |
HRSVA and HRSVB | 0(0) | 2(8.3) | 12(17.4) | 14(11.7) |
HCOV OC43 | 0(0) | 1(4.2) | 10(14.5) | 11(9.17) |
KLePSa L. pneumophila/ L. longbeache | 0(0) | 1(4.2) | 11(15.9) | 12(10) |
HCOV 229E | 0(0) | 1(4.2) | 9(13) | 10(8.3) |
M. pneumoniae | 0(0) | 4(16.7) | 5(7.2) | 9(7.5) |
HBoV | 0(0) | 0(0) | 8(11.6) | 8(6. 7) |
C. pneumoniae | 1(3.7) | 1(4.2) | 6(8.7) | 8(6. 7) |
HPIV2 | 0(0) | 1(4.2) | 7(10.1) | 8(6. 7) |
IAV | 1(3.7) | 1(4.2) | 2(2.9) | 4(3. 33) |
ICV | 0(0) | 0(0) | 2(2.9) | 2(1. 7) |
HPeV | 1(3.7) | 1(4.2) | 3(4.3) | 4(3.3) |
H. influenza | 0(0) | 0(0) | 1(1.4) | 1(0.8) |
HPIV3 | 1(3.7) | 1(4.2) | 4(5.8) | 2(1.7) |
HMPVA and B | 0(0) | 1(4.2) | 0(0) | 1(0.8) |
